Investing in innovation to fortify the future of mental health care

SEC Filing

Form

Filing Date

Feb 14, 2025

Document Date

Feb 14, 2025

Form Description

SCHEDULE 13G/A - Description

Company

Vistagen Therapeutics, Inc

Issuer

VistaGen Therapeutics, Inc.

View HTML

Annual Reports

Annual reports provide a comprehensive overview of the company for the past year

View Reports

Quarterly Reports

Quarterly reports provide a continuing view of the company's financial position

View Reports

SEC Filings

Statement of changes in beneficial ownership of securities

View Filings